Platform Technology Partners Eli Lilly & CO Transaction History

Platform Technology Partners

$311 Million
Q3 2024

A detailed history of Platform Technology Partners transactions in Eli Lilly & CO stock. As of the latest transaction made, Platform Technology Partners holds 2,152 shares of LLY stock, worth $1.65 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

2,152

Previous 2,239 3.89%

Holding current value

$1.65 Million

Previous $2.03 Million 5.97%

% of portfolio

0.61%

Previous 0.71%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$772.14 - $960.02 $67,176 - $83,521	-87 Reduced 3.89%	2,152 $1.91 Million
Q2 2024 Jul 30, 2024	BUY	$724.87 - $909.04 $107,280 - $134,537	148 Added 7.08%	2,239 $2.03 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $31,511 - $37,147	-60 Reduced 2.79%	2,091 $1.22 Million
Q3 2023 Nov 08, 2023	BUY	$434.7 - $599.3 $27,386 - $37,755	63 Added 3.02%	2,151 $1.16 Million
Q2 2023 Jul 12, 2023	BUY	$350.74 - $468.98 $15,783 - $21,104	45 Added 2.2%	2,088 $979,000
Q1 2023 Apr 04, 2023	BUY	$310.63 - $364.82 $56,845 - $66,762	183 Added 9.84%	2,043 $701,000
Q4 2022 Jan 11, 2023	BUY	$321.55 - $374.67 $9,324 - $10,865	29 Added 1.58%	1,860 $0
Q3 2022 Oct 24, 2022	BUY	$296.48 - $337.87 $1,482 - $1,689	5 Added 0.27%	1,831 $592,000
Q2 2022 Aug 04, 2022	BUY	$278.73 - $327.27 $278 - $327	1 Added 0.05%	1,826 $592,000
Q1 2022 May 03, 2022	SELL	$234.69 - $291.66 $19,713 - $24,499	-84 Reduced 4.4%	1,825 $523,000
Q4 2021 Feb 01, 2022	SELL	$224.85 - $279.04 $11,917 - $14,789	-53 Reduced 2.7%	1,909 $527,000
Q3 2021 Nov 04, 2021	SELL	$221.6 - $272.71 $588,348 - $724,045	-2,655 Reduced 57.5%	1,962 $453,000
Q2 2021 Aug 05, 2021	BUY	$180.55 - $233.54 $157,620 - $203,880	873 Added 23.32%	4,617 $1.06 Million
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $3,783 - $5,006	29 Added 0.78%	3,744 $632,000
Q3 2020 Nov 30, 2020	BUY	$146.22 - $169.13 $10,966 - $12,684	75 Added 2.06%	3,715 $550,000
Q2 2020 Nov 30, 2020	SELL	$136.42 - $164.18 $3,137 - $3,776	-23 Reduced 0.63%	3,640 $598,000
Q1 2020 Nov 30, 2020	BUY	$119.05 - $147.35 $436,080 - $539,743	3,663 New	3,663 $508,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Platform Technology Partners, based on Form 13F filings with the SEC.

News

Stay updated on Platform Technology Partners with notifications on news.

Account

Platform Technology Partners Eli Lilly & CO Transaction History